Acadia Healthcare's (ACHC) revenue and adjusted earnings before interest, taxes, depreciation and amortization for 2024 are expected to be affected by "softer-than-expected" volumes, RBC Capital Markets said in a note Monday.
The firm cut its revenue forecast to $3.16 billion from $3.20 billion and its adjusted EBITDA estimate to $730.1 million from $750.1 million on the anticipated soft volumes, partially offset by new facility openings.
For 2025, RBC reduced its revenue forecast for Acadia to $3.45 billion from $3.53 billion and adjusted EBITDA estimate to $781.4 million from $820.6 million in anticipation of "some volume softness" continuing through H1 of 2025.
The firm noted that the company's management attributed the softer volumes to the negative headlines that have surrounded Acadia since late September, when the company disclosed requests for information and subpoenas from separate agencies.
RBC lowered its price target on the company to $64 from $94 and maintained its outperform rating.
Acadia shares were down 3.4% in recent trading.
Price: 36.52, Change: -1.30, Percent Change: -3.44
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。